SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-155851
Filing Date
2016-11-09
Accepted
2016-11-09 16:07:01
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17160_110q.htm 10-Q 495881
2 EX-31.1 a16-17160_1ex31d1.htm EX-31.1 16650
3 EX-31.2 a16-17160_1ex31d2.htm EX-31.2 16679
4 EX-32.1 a16-17160_1ex32d1.htm EX-32.1 8095
5 EX-32.2 a16-17160_1ex32d2.htm EX-32.2 8138
  Complete submission text file 0001104659-16-155851.txt   2334806

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dprx-20160930.xml EX-101.INS 351342
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dprx-20160930.xsd EX-101.SCH 23574
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dprx-20160930_cal.xml EX-101.CAL 25636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dprx-20160930_def.xml EX-101.DEF 69541
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT dprx-20160930_lab.xml EX-101.LAB 241162
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dprx-20160930_pre.xml EX-101.PRE 164111
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 161984254
SIC: 2834 Pharmaceutical Preparations